PLoS Pathogens (Dec 2019)

PDGFRA defines the mesenchymal stem cell Kaposi's sarcoma progenitors by enabling KSHV oncogenesis in an angiogenic environment.

  • Julian Naipauer,
  • Santas Rosario,
  • Sachin Gupta,
  • Courtney Premer,
  • Omayra Méndez-Solís,
  • Mariana Schlesinger,
  • Virginia Ponzinibbio,
  • Vaibhav Jain,
  • Lauren Gay,
  • Rolf Renne,
  • Ho Lam Chan,
  • Lluis Morey,
  • Daria Salyakina,
  • Martin Abba,
  • Sion Williams,
  • Joshua M Hare,
  • Pascal J Goldschmidt-Clermont,
  • Enrique A Mesri

DOI
https://doi.org/10.1371/journal.ppat.1008221
Journal volume & issue
Vol. 15, no. 12
p. e1008221

Abstract

Read online

Kaposi's sarcoma (KS) is an AIDS-defining cancer caused by the KS-associated herpesvirus (KSHV). Unanswered questions regarding KS are its cellular ontology and the conditions conducive to viral oncogenesis. We identify PDGFRA(+)/SCA-1(+) bone marrow-derived mesenchymal stem cells (Pα(+)S MSCs) as KS spindle-cell progenitors and found that pro-angiogenic environmental conditions typical of KS are critical for KSHV sarcomagenesis. This is because growth in KS-like conditions generates a de-repressed KSHV epigenome allowing oncogenic KSHV gene expression in infected Pα(+)S MSCs. Furthermore, these growth conditions allow KSHV-infected Pα(+)S MSCs to overcome KSHV-driven oncogene-induced senescence and cell cycle arrest via a PDGFRA-signaling mechanism; thus identifying PDGFRA not only as a phenotypic determinant for KS-progenitors but also as a critical enabler for viral oncogenesis.